For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Bright Minds Biosciences Inc (NASDAQ: DRUG) closed at $84.66 in the last session, up 0.46% from day before closing price of $84.27. In other words, the price has increased by $0.46 from its previous closing price. On the day, 0.12 million shares were traded. DRUG stock price reached its highest trading level at $89.7066 during the session, while it also had its lowest trading level at $84.0.
Ratios:
We take a closer look at DRUG’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 36.10 and its Current Ratio is at 36.10. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, BTIG Research on September 08, 2025, initiated with a Buy rating and assigned the stock a target price of $72.
On May 07, 2025, Chardan Capital Markets started tracking the stock assigning a Buy rating and target price of $80.Chardan Capital Markets initiated its Buy rating on May 07, 2025, with a $80 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DRUG now has a Market Capitalization of 659261056 and an Enterprise Value of 545776000.
Stock Price History:
The Beta on a monthly basis for DRUG is -6.11, which has changed by 1.0973122 over the last 52 weeks, in comparison to a change of 0.14446163 over the same period for the S&P500. Over the past 52 weeks, DRUG has reached a high of $97.75, while it has fallen to a 52-week low of $23.17. The 50-Day Moving Average of the stock is 25.22%, while the 200-Day Moving Average is calculated to be 92.27%.
Shares Statistics:
According to the various share statistics, DRUG traded on average about 153.91K shares per day over the past 3-months and 161900 shares per day over the past 10 days. A total of 7.64M shares are outstanding, with a floating share count of 5.40M. Insiders hold about 30.69% of the company’s shares, while institutions hold 56.30% stake in the company. Shares short for DRUG as of 1764288000 were 270495 with a Short Ratio of 2.00, compared to 1761868800 on 233622. Therefore, it implies a Short% of Shares Outstanding of 270495 and a Short% of Float of 5.59.
Earnings Estimates
Bright Minds Biosciences Inc (DRUG) is presently subject to a detailed evaluation by 4.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is -$1.53, with high estimates of -$0.99 and low estimates of -$2.24.
Analysts are recommending an EPS of between -$4.19 and -$9.78 for the fiscal current year, implying an average EPS of -$6.9. EPS for the following year is -$7.7, with 4.0 analysts recommending between -$5.13 and -$10.37.
